Back to the search results

Evangelisches Amalie Sieveking Krankenhaus

Haselkamp 33
22359 Hamburg

Phone: 040-64411-0
Fax: 040-64411-225
Mail: ed.eilama@ofni

https://amalie.de
  • Number of beds: 341
  • Number of specialist departments: 7
  • Number of inpatient cases: 14.638
  • Number of partial inpatient cases: 182
  • Number of outpatient cases: 20.608
  • Hospital owners: Ev. Amalie Sieveking Krankenhaus gGmbH
  • Type of provider: freigemeinnützig
  • Academic teaching hospital
      • Universitätsklinikum Hamburg-Eppendorf (UKE)
External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung does not apply
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Quantity performed 77
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 0
Quantity forecast year: 21
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 77
Quantity forecast year: 66
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
108 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
76 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
58 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Is a protection concept in place? Yes
  • No care for children and young people
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

VA Anordnung von Medikamenten

11.08.2022

VA Anordnung von Medikamenten

11.08.2022

VA Anordnung von Medikamenten, VA Kurvenführung, VA RV-EM konforme Entlassung

11.08.2022

  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Prof. Dr. E. von Dobschütz: Albert-Ludwigs-Uni Freiburg // PD Dr. J. Kluwe: Uni HH (Med. Fakultät), TU Harburg (Maschinenbau) // Prof. Dr. C. Isbert: Uni Würzburg // Prof. Dr. C. Weber: Uni HH, University of Sharjah // Dr. W. Lütje: Medical School HH // Dr. E. Fritzsche --> University of Sharjah

Explanation

- in Kooperation mit der Charité Berlin zum Thema Geburtserleben von Männern in Abhängigkeit von Konzepten der Geburtsvorbereitung, Fr. Strüngmann - in Kooperation mit der Hebammenwissenschaft, Universität zu Lübeck zum Thema Gewalterfahrung in der Geburtshilfe am Beispiel Kristellern, Fr. Nolte

Explanation

15 Plätze für 7 Fachabteilungen der Klinik, die zeitgleich belegt werden können (Koordinator: Prof. Dr. Weber)

Explanation

Wellach, Ingmar (Hrsg.) „Praxisbuch EEG“, 2020, 3. Auflage.

Explanation

1) Prof. Dr. Christoph Isbert / Universitäten Hamburg und Würzburg 2) Dr. Dirk Becker und Dr. Ingmar Wellach: Gründungsmitglieder im „Parkinson-Netzwerk Deutschland“ 3.) PD Dr. Johannes: STOPPIT-Studie + Forschungsprojekte 'Portale Hypertension' (beide UKE)

Explanation

PD Dr. Johannes Kluwe: STOPPIT - Langzeit-Behandlung mit Protonenpumpenhemmern b. Patienten mit Leberzirrhose + Efficacy and Safety of Obeticholic Acid in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis

Training in other healing professions
Comment

Comment

Comment

Comment

Comment

Comment

Comment

RA Christopher Rama

Patientenfürsprecher

Haselkamp 33
22359 Hamburg

Phone: 040 -2805810-
Mail: ed.puhear@tsop

Anja Richter

Beschwerdemanagerin

Haselkamp 33
22359 Hamburg

Phone: 040 -64411-8439
Mail: ed.nenitreblaleunammi@rethciR.ajnA

Caterina Mambou

Leitung Qualitätsmanagement

Haselkamp 33
22359 Hamburg

Phone: 040 -64411-8587
Mail: ed.nenitreblaleunammi@uobmam.aniretac

Prof. Dr. med. Ernst von Dobschütz

Vorsitzender der Hygienekommission

Haselkamp 33
22359 Hamburg

Phone: 040 -64411-8529

Prof. Dr. med. Ernst von Dobschütz

Ärztlicher Direktor, Vorsitz der Arzneimittelkommission

Haselkamp 33
22359 Hamburg

Phone: 040 -664411-8529
Mail: ed.nenitreblaleunammi@zteuhcsbodnovtsnre

Kerstin Kaden

Schwerbehindertenbeauftragte

Haselkamp 33
22359 Hamburg

Phone: 040 -64411-8535
Mail: ed.nenitreblaleunammi@nedak.nitsrek

Haselkamp 33
22359 Hamburg

Phone: 040-64411-0
Fax: 040-64411-225
Mail: ed.eilama@ofni

Maike Sellentin

Pflegedirektorin

Haselkamp 33
22359 Hamburg

Phone: 040 -64411-250
Mail: ed.nenitreblaleunammi@nitnelles.ekiam

Andreas Schneider

Geschäftsführung

Haselkamp 33
22359 Hamburg

Phone: 040 -64411-221
Mail: ed.nenitreblaleunammi@redienhcs.saerdna

Andreas Schneider

Geschäftsführung

Haselkamp 33
22359 Hamburg

Phone: 040 -64411-221
Mail: ed.nenitreblaleunammi@redienhcs.saerdna

Prof. Dr. med. Ernst von Dobschütz

Ärztlicher Direktor / Chefarzt Endokrine Chirurgie

Haselkamp 33
22359 Hamburg

Phone: 040 -64411-8529
Mail: ed.nenitreblaleunammi@zteuhcsbodnov.tsnre

No

IK: 260200206

Location number: 772845000

Old location number: 772845000

Hospital portrait for download